Katrin Ericson retweeted
Learn about our group's efforts to apply AI Models to single cell RNA-seq data to find cures for RUNX1-FPD with @LabAgarwal @LabObeng @EricsonKatrin &
@RUNX1Research supported by @cziscience in @GenomeWeb.
@VUMCDiscoveries @VUMCgenetics genomeweb.com/informatics/ai…
Katrin Ericson retweeted
This Monday is our #MedEd webinar to discuss the impact of molecular profiling in #MDS & #AML patient outcomes. Dr. @DanPollyea of @CUHematology presents & joins a Q&A with Dr. @SmithLabSF from @ucsf & Dr. Amir Fathi from @MGHCancerCenter. Register now:
ow.ly/sVZP50Q5Je4
Check out this @genomenon webinar on Sept 21st focused on the classification of splice variants in hereditary cancer genes with guest speaker Dr. Randi Rawson of @myriadgenetics
Check out this open grant opportunity established by our friends at @AlexsLemonade. Here's to accelerating discoveries for effective treatments for all children with cancers.
.@AlexsLemonade is now accepting applications for its 2024 Innovation Grant. The grant is designed to provide critical & significant seed funding for researchers with a novel approach to #pediatriconcology scientific investigation. Click here for details: ow.ly/avHp50PISQz
1
175
Katrin Ericson retweeted
Results from a recent clinical trial suggest that a new three-drug regimen might reduce the risk of graft-versus-host disease after stem cell transplant, potentially making a significant step toward improving patient outcomes. Learn more from this @theNCI article.
A three-drug regimen was more effective than the standard therapy at preventing graft-versus-host disease in people with blood cancers receiving well-matched allogeneic stem cell transplants. spr.ly/6019P9Kz9 #GHVD
Katrin Ericson retweeted
ONE WEEK away from the deadline to submit your research abstracts for potential inclusion in our 7th Annual Scientific Conference poster session! Submission is open to anyone, so please share this opportunity and these guidelines within your network: ow.ly/ftGr50PeyJu
Katrin Ericson retweeted
Register for our next #MedEd webinar, “Pulling the Molecular Thread Through Pediatric Thrombocytopenia, MDS and AML” on Monday, Sept. 11!
Experts from @ChildrensPhila & @Stanford will discuss the importance of accurate diagnoses with these conditions. ow.ly/cRzb50PgFQ4
Great opportunity to submit your RUNX1-FPD preclinical model project proposals! Please submit an LOI.
Calling all #RUNX1 researchers! The @NIH's @NCATS & @NIMH have launched a funding opportunity that supports therapeutic development for #rarediseases. From efficacy to clinical trials, this could be your chance to make an impact! LOIs are due by Sept 1st: grants.nih.gov/grants/guide/…
Katrin Ericson retweeted
Academics outside the US can now apply to access @AllofUsResearch. Please spread the word!
allofus.nih.gov/news-events/…
cc: @dgmacarthur @ceclindgren @timfrayling @minouye271 @nicolesoranzo @GLettre @samrip @ShaiCarmi @jgustavsmith @andganna @PaulLacaze @drjamesware @nickywhiffin
Katrin Ericson retweeted
We are close to the end of the #XOutCancer campaign. Help us raise awareness and funds for cancer prevention research that has the potential to save lives. Support the campaign now through June 4th! #cancerresearch #bloodcancer
ow.ly/FBao50NRtm1
It's our annual RRP X-Out Cancer campaign. Please help me raise money for RUNX1-FPD research. You all know how expensive research is. Your gift means a lot. Plus, I pledged to run 21 days of the month in honor of RUNX1 on chromosome 21. Thank you! ♥️
givebutter.com/xout23/katrin…
6
660
Katrin Ericson retweeted
RRP & @AlexsLemonade are thrilled to announce that Dr. Brittany Stewart received a 2023 RRP-ALSF RUNX1 Early Career Investigator-Clinical Research Grant! Learn more about her plans to develop the first guidelines for the diagnosis & treatment of RUNX1-FPD: ow.ly/uugl50Ok3KX
Congratulations to an incredibly talented young scientist! Dr. @amycfanphd has made a huge impact on the RUNX1 research field not only b/c of her thesis work but b/c she is a wonderful human being, easy to collaborate with and filled with a passion to make a difference for pts.
Congrats to Dr. @amycfanphd for successfully defending her PhD thesis on “Genetic blood disorders and inflammation: Characterizing cell autonomous & non-autonomous contributions of RUNX1 loss in hematopoiesis and leukemogenesis” 👏🎉!! #StanfordImmuno #thesisdefense #PhD
6
496
Germline predispositions to MDS.. not that rare! Way to go @KellyLBolton!! Congratulations!
Replying to @KellyLBolton
@KellyLBolton @WUSTLmed wins this year’s @MDSFoundation young investigator award and is giving an engaging keynote lecture in germline predisposition to #MDSsm #MDS2023
Katrin Ericson retweeted
Today’s the day to begin to Walk & Roll with the 2023 X-Out Cancer Challenge! Join us throughout the month of May by walking (or running, or rolling) toward a cure for #RUNX1FPD. 🏃
Support, participate and donate through the link below! #PREVENTCANCER
ow.ly/FBao50NRtm1
Katrin Ericson retweeted
4 more days !!! To fill out this survey. Data will be presented during SSC session @isth
The SSC on genomics in T&H would like to obtain knowledge about the availability of a genetic diagnosis of having an inherited platelet disorder "around the globe". Pls forward this link to collaborators esp in Asia, Africa & SouthAmerica forms.gle/udFLf7G7L8wybS75A
Katrin Ericson retweeted
We’re taking to the road for this year’s #XOutCancer Campaign w/ the RRP Walk & Roll! Join us for a virtual walk/run to raise funds & awareness for #RUNX1FPD & cancer prevention research. 💪Click the link below to learn more, donate & spread the word! 🏃
ow.ly/FBao50NRtm1
Beautiful work by @jaiswalmdphd, @AlexBickMDPhD and colleagues. Fascinating to learn that specific somatic mutations in HSCs drive expression of TCL1A which in turn promotes clonal expansion.
Clonal hematopoiesis is an expansion of blood stem cell clones caused by mutations in a recurrent set of genes. Our paper on factors mediating expansion of these mutant clones is published today.
nature.com/articles/s41586-0…
Thread below...
1
3
474
Katrin Ericson retweeted
Learn about the value & power of molecular profiling in improving outcomes for MDS & AML patients at RRP's #meded webinar Wed, April 26 w/ Dr. @DanPollyea & guest panelists Dr. Eytan Stein @MSKCancerCenter & Dr. Gabriel Mannis @StanfordHealth
Register: ow.ly/kAIf50NolCP
Loved catching up with my forever mentor Dr. Hanna Mikkola @ASH_hematology. She can still get me so fired up about HSC biology!!


























